Zydus Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	8,552	8,268	4,130	5,731	11,069
Short-Term Investments	-	36,857	42,747	6,875	-	5,134
Trading Asset Securities	-	4,302	5,401	2,525	6,193	23,532
Cash & Short-Term Investments	49,711	49,711	56,416	13,530	11,924	39,735
Cash Growth	-11.82%	-11.88%	316.97%	13.47%	-69.99%	265.48%
Accounts Receivable	-	54,157	40,848	52,202	44,168	33,403
Other Receivables	-	2,098	4,426	3,551	2,181	1,991
Receivables	-	56,292	46,045	55,768	46,353	35,394
Inventory	-	56,281	39,440	34,419	34,133	37,194
Prepaid Expenses	-	3,987	1,144	1,021	1,016	721
Other Current Assets	-	32,790	27,416	9,460	6,656	7,908
Total Current Assets	-	199,061	170,461	114,198	100,082	120,952
Property, Plant & Equipment	-	103,964	73,599	69,148	68,267	64,226
Long-Term Investments	-	17,659	15,570	9,696	11,779	9,348
Goodwill	-	75,427	52,421	52,660	48,044	53,646
Other Intangible Assets	-	98,652	32,236	26,110	10,905	11,272
Long-Term Deferred Tax Assets	-	21,086	23,438	16,442	12,624	10,958
Other Long-Term Assets	-	8,215	4,292	4,554	5,843	7,552
Total Assets	-	524,066	372,017	292,808	257,564	277,954

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	-	28,451	22,807	21,267	21,250	21,378
Accrued Expenses	-	22,114	20,261	15,385	15,454	13,118
Short-Term Debt	-	86,001	31,743	7,863	10,812	33,142
Current Portion of Long-Term Debt	-	-	-	-	822	5,198
Current Portion of Leases	-	582	116	105	119	88
Current Income Taxes Payable	-	3,663	6,157	3,720	1,568	418
Current Unearned Revenue	-	363	23	-	-	-
Other Current Liabilities	-	15,945	9,309	5,079	5,282	5,052
Total Current Liabilities	-	157,119	90,416	53,419	55,307	78,394
Long-Term Debt	-	31,880	-	-	-	3,621
Long-Term Leases	-	6,683	321	251	198	161
Long-Term Unearned Revenue	-	-	-	18	295	287
Pension & Post-Retirement Benefits	-	4,453	3,839	3,097	2,718	3,250
Long-Term Deferred Tax Liabilities	-	17,340	5,126	4,465	1,944	1,538
Other Long-Term Liabilities	-	10,769	8,731	10,542	219	165
Total Liabilities	-	228,244	108,433	71,792	60,681	87,416

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	-	1,006	1,006	1,006	1,012	1,024
Retained Earnings	-	287,251	247,988	206,062	181,163	172,855
Comprehensive Income & Other	-	-17,143	-9,463	-8,773	-7,017	-3,883
Total Common Equity	271,114	271,114	239,531	198,295	175,158	169,996
Minority Interest	-	24,708	24,053	22,721	21,725	20,542
Shareholders' Equity	295,822	295,822	263,584	221,016	196,883	190,538
Total Liabilities & Equity	-	524,066	372,017	292,808	257,564	277,954

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	125,146	125,146	32,180	8,219	11,951	42,210
Net Cash (Debt)	-75,435	-75,435	24,236	5,311	-27	-2,475
Net Cash Growth	-	-	356.34%	-	-	-
Net Cash Per Share	-74.98	-74.97	24.09	5.25	-0.03	-2.42
Filing Date Shares Outstanding	1,005	1,006	1,006	1,006	1,012	1,024
Total Common Shares Outstanding	1,005	1,006	1,006	1,006	1,012	1,024
Working Capital	-	41,942	80,045	60,779	44,775	42,558
Book Value Per Share	269.43	269.43	238.05	197.07	173.05	166.05
Tangible Book Value	97,035	97,035	154,874	119,525	116,209	105,078
Tangible Book Value Per Share	96.43	96.43	153.91	118.78	114.81	102.64
Land	-	9,596	6,424	6,170	6,258	5,727
Buildings	-	39,724	23,733	21,906	20,748	19,688
Machinery	-	107,232	86,460	80,775	74,985	71,260
Construction In Progress	-	11,657	13,179	11,115	11,302	6,610